Insolvencies Shake German Industry: PMC Rehna and Molecular Health GmbH Struggle Amid Financial Pressures
PMC GmbH and Molecular Health GmbH, two German firms, filed for insolvency on June 1, 2026, citing financial difficulties and client losses, while seeking restructuring solutions.
- • PMC GmbH from Rehna filed for insolvency due to poor client payment practices and is seeking investors.
- • Molecular Health GmbH entered insolvency after losing a major client; one business division will be sold, and core business spun off as Lucera.
- • PMC specialized in lightweight rail vehicle components including Berlin U-Bahn seats.
- • Molecular Health operates software for precision medicine and is owned by Dievini-Holding linked to SAP co-founder Dietmar Hopp.
- • German corporate insolvencies increased by 10.3% in 2025, reflecting broader economic challenges.
Key details
Two notable German companies, PMC GmbH from Rehna and Molecular Health GmbH from Heidelberg, have filed for insolvency as of June 1, 2026, highlighting ongoing financial challenges in the German corporate sector.
PMC GmbH, specializing in lightweight solutions for the rail vehicle industry, ceased operations with employee layoffs following its insolvency filing. The company, known for producing composite material products including Berlin U-Bahn seats and submarine components, cited declining payment morale from major clients as a critical cause for its financial difficulties. Despite prior investments and a peak workforce of around 30 employees, PMC is actively seeking investors and exploring restructuring options to revive the business. The rise in insolvencies aligns with a broader trend in Germany, as corporate insolvencies increased by 10.3% in 2025.
Meanwhile, Molecular Health GmbH, a biotechnology firm owned predominantly by Dievini-Holding associated with SAP co-founder Dietmar Hopp, entered insolvency following the loss of a significant client. The company, which develops software for precision and in-silico medicine, is undergoing an insolvency process managed under Eigenverwaltung, allowing current management to retain control with external supervision. A major restructuring effort will preserve only one of its two business divisions, slated for sale to an international investor group, potentially saving about half of the firm’s 60 jobs. Furthermore, Molecular Health’s core operations have already been spun off into a startup named Lucera, which employs 25 former Molecular Health staff members.
These insolvencies underscore the volatility in certain German industries amidst complex client relationships and market pressures. Both companies are managing their insolvency within frameworks aimed at restructuring and potential recovery, illustrating both the challenges and resilience within Germany’s sectoral landscape.
This article was translated and synthesized from German sources, providing English-speaking readers with local perspectives.
Source articles (2)
Source comparison
Company names
Sources report different companies filing for insolvency
nordkurier.de
"PMC GmbH, a company based in Rehna, has filed for insolvency effective June 1, 2026."
merkur.de
"Molecular Health GmbH, a biotechnology company based in Heidelberg, has entered insolvency proceedings as of June 1, 2026."
Why this matters: One source discusses PMC GmbH while the other reports on Molecular Health GmbH. This discrepancy is significant as it involves entirely different companies and their respective situations.
Latest news
DFB Prepares Bid to Host FIFA World Cup in Germany in 2038 or 2042
FC St. Pauli Ends Cooperation with Head Coach Alexander Blessin Amid Relegation
NRW Ministry Proposes Comprehensive Teacher Training Reforms to Combat Shortages
Insolvencies Shake German Industry: PMC Rehna and Molecular Health GmbH Struggle Amid Financial Pressures
Germany Faces Diplomatic Setback After UN Security Council Seat Bid Fails
Germany’s UN Security Council Defeat: Political Fallout and Diplomatic Challenges
The top news stories in Germany
Delivered straight to your inbox each morning.